1-3 of 3
Jerôme Stirnemann
Close
Sort by
Journal Articles

Persistence of Imiglucerase in Cell Compartment Explains Dosing Frequency of Every Two Weeks in Type 1 Gaucher Disease

Juliette Berger, PhD, Marie Vigan, PhD, Jérôme Stirnemann, PD, PhD Professor, Céline Bourgne, PhD, Alexandre Janel, PhD, Nadia Belmatoug, MD, Christian Rose, MD, Monia Bengherbia, Bruno Pereira, France Mentré, MD PhD Professor, Marc G Berger, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1396.
https://doi.org/10.1182/blood.V124.21.1396.1396
Published: 2014
Journal Articles

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

Clinical Trials & Observations
Bertrand Godeau, Raphael Porcher, Olivier Fain, François Lefrère, Pierre Fenaux, Stéphane Cheze, Anne Vekhoff, Marie-Paule Chauveheid, Jerôme Stirnemann, Lionel Galicier, Emmanuelle Bourgeois, Stéphanie Haiat, Bruno Varet, Michel Leporrier, Thomas Papo, Mehdi Khellaf, Marc Michel, Philippe Bierling
Journal: Blood
Blood (2008) 112 (4): 999–1004.
https://doi.org/10.1182/blood-2008-01-131029
Published: 2008
Journal Articles

Rituximab Is an Alternative to Splenectomy in Adults with Chronic Immune Thrombocytopenic Purpura: Results of a Multicenter Prospective Phase 2 Study.

Bertrand Godeau, MD, Olivier Fain, MD, Raphael Porcher, MD, PhD, Francois Lefrere, MD, Pierre Fenaux, MD, PhD, Stephane Cheze, MD, Anne Vekhoff, MD, Marie-Paule Chauveheid, MD, Jerome Stirnemann, MD, Lionel Galicier, MD, Emmanuelle Bourgeois, MD, Stephanie Haiat, MD, Bruno Varet, MD, Michel Leporrier, MD, Thomas Papo, MD, Marc Michel, MD, Philippe Bierling, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 478.
https://doi.org/10.1182/blood.V108.11.478.478
Published: 2006